| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.88B | -0.9% |
| Cost of Revenue | $1.45B | +0.4% |
| Gross Profit | $428.8M | -4.9% |
| R&D Expense | $27.1M | +10.6% |
| SG&A Expense | $237.8M | +7.2% |
| Operating Income | $102.7M | -50.0% |
| Pre-tax Income | $53.9M | -67.1% |
| Income Tax | $9.7M | -83.9% |
| Net Income | $44.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.2M | +17.9% |
| Accounts Receivable | $211.9M | -12.1% |
| Inventory | $290.4M | +1.1% |
| Current Assets | $613.3M | -5.1% |
| Total Assets | $1.86B | +1.3% |
| Current Liabilities | $516.7M | +17.4% |
| Long-term Debt | $647.0M | -4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $125.3M | -63.8% |
| Investing Cash Flow | -$206.7M | -19.6% |
| Financing Cash Flow | $89.3M | +145.3% |
| -57.3% |
| EPS (Basic) | $0.76 | -56.6% |
| EPS (Diluted) | $0.76 | -56.1% |
| Stockholders' Equity |
| $474.9M |
| -0.8% |